Warfarin reversal: Difference between revisions
(Created page with "Vitamin K Guidelines for Warfarin (Coumadin) Reversal== == ==Excessive Anticoagulation== ===INR < 5 No Bleeding=== 1. ↓ dose or omit dose 2. Resume at ↓ dose ...") |
No edit summary |
||
| Line 1: | Line 1: | ||
Vitamin K Guidelines for Warfarin (Coumadin) Reversal | ==Background== | ||
Vitamin K Guidelines for Warfarin (Coumadin) Reversal | |||
==Excessive Anticoagulation== | ==Excessive Anticoagulation== | ||
===INR < 5 No Bleeding=== | ===INR < 5 No Bleeding=== | ||
#↓ dose or omit dose | |||
#Resume at ↓ dose once INR therapeutic | |||
===INR 5-9 No Bleeding=== | ===INR 5-9 No Bleeding=== | ||
# Omit 1-2 doses | |||
# Resume at ↓ dose once INR therapeutic | |||
# Vit K 1-2.5mg po if patient is at high risk for bleeding | |||
===INR ≥ 9 No Bleeding === | ===INR ≥ 9 No Bleeding === | ||
# Hold warfarin | |||
# Vit K 2.5-5mg po | |||
# INR will ↓ in 24-48h | |||
==Specific Reversal Reasons== | |||
===Reversal for patients undergoing surgery=== | |||
# Omit dose | |||
# Give vit K 2-4mg po | |||
# ↓ in INR will occur in 24h | |||
# If INR still high, may give additional Vit K 1-2mg po | |||
===INR therapeutic or elevated with Serious Bleeding=== | ===INR therapeutic or elevated with Serious Bleeding=== | ||
# Hold warfarin | |||
# Vit K 5-10mg subQ/IV | |||
# FFP | |||
# PCC or rFVIIa | |||
# Vit K may be repeated q12h | |||
==Treatment== | |||
#Oral route for vitamin K is preferred due to superior efficacy compared to subcutaneous route. #Oral vitamin K is available in tablet and solution formulations. | |||
==Source== | |||
Source | |||
Ansell J, Hirsh J, Poller L et al. The Pharmacology and Management of the Vitamin K Antagonists. CHEST. 126(3S):204S-233S. | Ansell J, Hirsh J, Poller L et al. The Pharmacology and Management of the Vitamin K Antagonists. CHEST. 126(3S):204S-233S. | ||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
[[Category:Tox]] | |||
Revision as of 13:48, 15 March 2011
Background
Vitamin K Guidelines for Warfarin (Coumadin) Reversal
Excessive Anticoagulation
INR < 5 No Bleeding
- ↓ dose or omit dose
- Resume at ↓ dose once INR therapeutic
INR 5-9 No Bleeding
- Omit 1-2 doses
- Resume at ↓ dose once INR therapeutic
- Vit K 1-2.5mg po if patient is at high risk for bleeding
INR ≥ 9 No Bleeding
- Hold warfarin
- Vit K 2.5-5mg po
- INR will ↓ in 24-48h
Specific Reversal Reasons
Reversal for patients undergoing surgery
- Omit dose
- Give vit K 2-4mg po
- ↓ in INR will occur in 24h
- If INR still high, may give additional Vit K 1-2mg po
INR therapeutic or elevated with Serious Bleeding
- Hold warfarin
- Vit K 5-10mg subQ/IV
- FFP
- PCC or rFVIIa
- Vit K may be repeated q12h
Treatment
- Oral route for vitamin K is preferred due to superior efficacy compared to subcutaneous route. #Oral vitamin K is available in tablet and solution formulations.
Source
Ansell J, Hirsh J, Poller L et al. The Pharmacology and Management of the Vitamin K Antagonists. CHEST. 126(3S):204S-233S.
